Chronic administration of neuropeptide Y into the lateral ventricle inhibits both the pituitary-testicular axis and growth hormone and insulin-like growth factor I secretion in intact adult male rats - PubMed (original) (raw)
Chronic administration of neuropeptide Y into the lateral ventricle inhibits both the pituitary-testicular axis and growth hormone and insulin-like growth factor I secretion in intact adult male rats
D D Pierroz et al. Endocrinology. 1996 Jan.
Abstract
Neuropeptide Y (NPY) is known to be involved in the central regulation of appetite, sexual behavior, and reproductive function. Whereas central administration of NPY strongly stimulates feeding in satiated animals, diet restriction or other unfavorable metabolic situations, such as diabetes, produce enhanced NPY gene expression and NPY release in the hypothalamus. Numerous studies have indicated that acute central administration of NPY results in various actions on LH secretion in the rat, either stimulatory or inhibitory. We recently demonstrated that chronic infusion of NPY into the lateral ventricle of adult intact female rats profoundly inhibited both the gonadotropic and somatotropic axes, with disruption of estrous cyclicity. Furthermore, we showed that central chronic infusion of NPY delayed sexual maturation in female rats. To analyze the effects of the same type of chronic NPY treatment on the pituitary-testicular axis, 45-day-old Sprague-Dawley male rats were implanted with stainless steel cannulas in the right lateral ventricle. Ten days later, Alzet osmotic minipumps were filled with different NPY solutions, adjusted to deliver 6, 18, or 36 micrograms/day, connected to the intracerebroventricular (icv) cannula, and sc implanted dorsally. The effects of these treatments were evaluated over 7 days. In one case, rats were castrated 5 days after initiation of NPY treatment, and the effect of castration was evaluated 2 days later. Chronic icv infusion of NPY produced the expected dose-related increases in food intake from 33.0 +/- 0.9 (basal) to 53.4 +/- 3.3 g/day (18 micrograms NPY/day) and body weight gain (5.7 +/- 0.7 to 10.5 +/- 1.2 d/day). As in female rats, this orexigenic action of NPY resulted in a significant dose-related decrease in pituitary weight, from 12.4 +/- 0.7 to 9.9 +/- 0.4 mg. The 7-day NPY infusion produced highly significant decreases in seminal vesicle weight (853 +/- 77 to 230 +/- 31 mg) and testis weight (3.82 +/- 0.09 to 3.18 +/- 0.15 g; P = 0.003). Plasma levels of testosterone (231 +/- 71 to 48 +/- 13 ng/dl), LH (20.7 +/- 3.7 to 9.1 +/- 1.2 ng/ml), and FSH (282 +/- 17 to 190 +/- 18 ng/ml) were markedly decreased at the 18 micrograms/day dosage, as also demonstrated for the 36 micrograms/day dosage. None of these effects was observed if vehicle was infused into the lateral ventricle instead of the NPY solution. When bilateral orchidectomy was performed 5 days after initiation of the NPY infusion (18 micrograms/day), the immediate LH and FSH rises usually seen after castration were seriously blunted.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
- Neuropeptide Y administered chronically into the lateral ventricle profoundly inhibits both the gonadotropic and the somatotropic axis in intact adult female rats.
Catzeflis C, Pierroz DD, Rohner-Jeanrenaud F, Rivier JE, Sizonenko PC, Aubert ML. Catzeflis C, et al. Endocrinology. 1993 Jan;132(1):224-34. doi: 10.1210/endo.132.1.8380374. Endocrinology. 1993. PMID: 8380374 - Evidence that neuropeptide Y could represent a neuroendocrine inhibitor of sexual maturation in unfavorable metabolic conditions in the rat.
Gruaz NM, Pierroz DD, Rohner-Jeanrenaud F, Sizonenko PC, Aubert ML. Gruaz NM, et al. Endocrinology. 1993 Oct;133(4):1891-4. doi: 10.1210/endo.133.4.8404631. Endocrinology. 1993. PMID: 8404631 - Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axes.
Raposinho PD, Castillo E, d'Alleves V, Broqua P, Pralong FP, Aubert ML. Raposinho PD, et al. Endocrinology. 2000 Dec;141(12):4419-27. doi: 10.1210/endo.141.12.7842. Endocrinology. 2000. PMID: 11108250 - Metabolic control of sexual function and growth: role of neuropeptide Y and leptin.
Aubert ML, Pierroz DD, Gruaz NM, d'Allèves V, Vuagnat BA, Pralong FP, Blum WF, Sizonenko PC. Aubert ML, et al. Mol Cell Endocrinol. 1998 May 25;140(1-2):107-13. doi: 10.1016/s0303-7207(98)00058-6. Mol Cell Endocrinol. 1998. PMID: 9722177 Review. - CNS-periphery relationships and body weight homeostasis: influence of the glucocorticoid status.
Jeanrenaud B, Rohner-Jeanrenaud F. Jeanrenaud B, et al. Int J Obes Relat Metab Disord. 2000 Jun;24 Suppl 2:S74-6. doi: 10.1038/sj.ijo.0801283. Int J Obes Relat Metab Disord. 2000. PMID: 10997614 Review.
Cited by
- Arcuate Nucleus of the Hypothalamus: Anatomy, Physiology, and Diseases.
Song J, Choi SY. Song J, et al. Exp Neurobiol. 2023 Dec 31;32(6):371-386. doi: 10.5607/en23040. Exp Neurobiol. 2023. PMID: 38196133 Free PMC article. Review. - A missense mutation in zinc finger homeobox-3 (ZFHX3) impedes growth and alters metabolism and hypothalamic gene expression in mice.
Nolan PM, Banks G, Bourbia N, Wilcox AG, Bentley L, Moir L, Kent L, Hillier R, Wilson D, Barrett P, Dumbell R. Nolan PM, et al. FASEB J. 2023 Oct;37(10):e23189. doi: 10.1096/fj.202201829R. FASEB J. 2023. PMID: 37713040 Free PMC article. - An appetite for growth: The role of the hypothalamic - pituitary - growth hormone axis in energy balance.
Dumbell R. Dumbell R. J Neuroendocrinol. 2022 Jun;34(6):e13133. doi: 10.1111/jne.13133. Epub 2022 Apr 26. J Neuroendocrinol. 2022. PMID: 35474620 Free PMC article. Review. - A Comparative Update on the Neuroendocrine Regulation of Growth Hormone in Vertebrates.
Vélez EJ, Unniappan S. Vélez EJ, et al. Front Endocrinol (Lausanne). 2021 Feb 23;11:614981. doi: 10.3389/fendo.2020.614981. eCollection 2020. Front Endocrinol (Lausanne). 2021. PMID: 33708174 Free PMC article. Review. - Sirtuin (SIRT)-1: At the crossroads of puberty and metabolism.
Aylwin CF, Lomniczi A. Aylwin CF, et al. Curr Opin Endocr Metab Res. 2020 Oct;14:65-72. doi: 10.1016/j.coemr.2020.06.001. Epub 2020 Jun 12. Curr Opin Endocr Metab Res. 2020. PMID: 32905232 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous